Literature DB >> 10462068

Cannabinoids as potential new analgesics.

J A Fuentes1, M Ruiz-Gayo, J Manzanares, G Vela, I Reche, J Corchero.   

Abstract

Among other pharmacological properties analgesia is one of the important features of cannabinoids with therapeutical prospects. Cannabinoids have been shown to produce antinociception in experimental animals and humans. Recently a new system of neuromodulation based upon the existence of cannabinoid receptors and their endogenous agonists has emerged. This has been proposed as another of the endogenous pain control systems. Current evidence indicate an interaction between cannabinoid and opioid systems, the latter being of known relevance in nociception. The fact that either exogenous or endogenous opioids enhanced cannabinoid-induced antinociception suggests simultaneous activation of both opioid and cannabinoid receptors by drugs as a new analgesic strategy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10462068     DOI: 10.1016/s0024-3205(99)00290-8

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  13 in total

Review 1.  Mechanism of cancer pain.

Authors:  Brian L Schmidt; Darryl T Hamamoto; Donald A Simone; George L Wilcox
Journal:  Mol Interv       Date:  2010-06

Review 2.  [Cannabinoids--signal transduction and mode of action].

Authors:  R Rukwied; B Gauter; M Schley; C Konrad
Journal:  Schmerz       Date:  2005-11       Impact factor: 1.107

Review 3.  Strategies for the treatment of cancer pain in the new millennium.

Authors:  C Ripamonti; E D Dickerson
Journal:  Drugs       Date:  2001       Impact factor: 9.546

4.  Anandamide activates peripheral nociceptors in normal and arthritic rat knee joints.

Authors:  S D Gauldie; D S McQueen; R Pertwee; I P Chessell
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

Review 5.  Drug interactions with patient-controlled analgesia.

Authors:  Jorn Lotsch; Carsten Skarke; Irmgard Tegeder; Gerd Geisslinger
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

6.  [Delta(9)-tetrahydrocannabinol and the opioid receptor agonist piritramide do not act synergistically in postoperative pain].

Authors:  W Seeling; L Kneer; B Büchele; J E Gschwend; L Maier; C Nett; T Simmet; P Steffen; M Schneider; M Rockemann
Journal:  Anaesthesist       Date:  2006-04       Impact factor: 1.041

Review 7.  Role of endocannabinoid system in mental diseases.

Authors:  Jorge Manzanares; Leyre Urigüen; Gabriel Rubio; Tomás Palomo
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

Review 8.  Pruritus in chronic liver disease: mechanisms and treatment.

Authors:  Nora V Bergasa
Journal:  Curr Gastroenterol Rep       Date:  2004-02

9.  Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes.

Authors:  J Manzanares; Md Julian; A Carrascosa
Journal:  Curr Neuropharmacol       Date:  2006-07       Impact factor: 7.363

10.  Peripheral cannabinoids attenuate carcinoma-induced nociception in mice.

Authors:  Andre V Guerrero; Phuong Quang; Nusi Dekker; Richard C K Jordan; Brian L Schmidt
Journal:  Neurosci Lett       Date:  2008-01-08       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.